Polymun Scientific Immunbiologische Forschung GmbH Company Profile

21:07 EST 10th December 2018 | BioPortfolio

Polymun was founded in 1992 by Prof. Hermann Katinger. It is a private company fully owned by the Katinger family. Revenues are generated by contract development and manufacturing as well as creating liposomal formats of drugs for contract partners. These revenues are invested in the proprietary product pipeline and the further development of technology platforms. The R&D projects and technologies are open for co-development and licensing. Polymun operates in accordance with current GMP guidelines and holds an Austrian production license for pharmaceuticals (§63 Austrian Pharmaceutical Law) thus meeting the EU requirements for drug manufacturing. The last inspection has taken place in September 2008.

Competence & Services
The core competence of Polymun is the development and manufacture of biopharmaceuticals, using both mammalian mammalian and microbial cell technology. A fine example are Polymun′s broadly neutralizing HIV-1 antibodies produced in CHO cells. Other examples are recombinant human and porcine trypsin produced in yeast. Cell culture was also the basis for the development of a live attenuated influenza vaccine produced in Vero cells which led to the further investigation in genetically modified influenza viruses used as carrier for foreign epitopes (HIV, TB). Also the innovative liposome technology was initiated in order to optimize the formulation of the pharmacologically potent enzyme SOD, produced by Polymun in E. coli. Today, Polymun can apply this drug delivery platform to all kinds of pharmaceutically active ingredients. The industrial applicability in scale and price is a common focus throughout all projects and technologies.


Donaustr. 99


Phone: +43 2243 25060 303
Fax: +43 2243 25060 399

News Articles [632 Associated News Articles listed on BioPortfolio]

Novartis beendet Forschung zu Infektionskrankheiten

Zürich (awp) - Der Pharmakonzern Novartis verabschiedet sich aus der Forschung bei Infektionskrankheiten. Dem Rückzug sollen laut einem Bericht der Nachrichtenagentur Bloomberg 140 Stellen an der a....

Neueste Stevia-Forschung im Journal of Nutrition veröffentlicht

CHICAGO, 25. Juli 2018 /PRNewswire/ -- The Journal of Nutrition veröffentlichte in seiner Ausgabe vom Juli 2018 eine ausführliche Übersichtsarbeit über die neueste wissenschaftliche Stevia-Forschu...

Affymetrix Genechip Fluidics Station 400/450 Genetik Forschung Flüssig

EUR 408,47Angebotsende: Freitag Dez-28-2018 16:06:23 CETSofort-Kaufen für nur: EUR 408,47Sofort-Kaufen | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : Affymetrix Genechip Fluidics ...

Affymetrix Genechip Fluidics Station 450 Flüssig Handhabung Genetic Forschung

EUR 361,37Angebotsende: Montag Dez-31-2018 16:21:51 CETSofort-Kaufen für nur: EUR 361,37Sofort-Kaufen | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : Affymetrix Genechip Fluidics S...

KIT erklimmt nächste Stufe: Bund und Land treiben Weiterentwicklung entschlossen voran

Um das Karlsruher Institut für Technologie (KIT) in seiner wissenschaftlichen Leistungsfähigkeit weiter zu unterstützen und konsequent fortzuentwickeln, wollen Bund und Land die mutige Fusion von 2...

New financing round at oncgnostics GmbH close

The life sciences company oncgnostics GmbH was able to double its investment of 750,000 euros following the very rapid and successful completion of its second crowd investing campaign on Seedmatch. A...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Innovative Projekte im Bereich der angewandten Forschung – "Deutsch-Ägyptischer Forschungsfond" (GERF)

PubMed Articles [505 Associated PubMed Articles listed on BioPortfolio]

45th meeting of the Arbeitsgemeinschaft Dermatologische Forschung.

Vascularization, Regeneration and Tissue Engineering.

22nd Surgical Research Days.

Scientific dissemination in the field of public health. The experience of The National Health Institute.

Traditionally, research institutions have focused their efforts on generating scientific knowledge and disseminating it through traditional mechanisms such as scientific publications. Recently, severa...

Changes in perceived scientific consensus shift beliefs about climate change and GM food safety.

Despite an overwhelming scientific consensus, a sizable minority of people doubt that human activity is causing climate change. Communicating the existence of a scientific consensus has been suggested...

Clinical Trials [684 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

The Boston Scientific ENOVUS Trial

A prospective, actively controlled, consecutively enrolling, non-randomized multi center clinical evaluation of the safety and efficacy of the Boston Scientific ENOVUS AAA Endograft when u...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Boston Scientific COMET Wire Validation Study

Summary of Study Aims To assess, in a randomised fashion: 1. performance of Boston Scientific Pressure Wire versus St Jude Pressure Wire 2. performance of Boston Scientific Pr...

Companies [1477 Associated Companies listed on BioPortfolio]

Polymun Scientific Immunbiologische Forschung GmbH

Polymun was founded in 1992 by Prof. Hermann Katinger. It is a private company fully owned by the Katinger family. Revenues are generated by contract development and manufacturing as well as creatin...

Medizinische Forschung GmbH

CorTrial is a professional physician owned and staffed medium sized Contract Research Organisation for the execution and evaluation of clinical trials (phase I – IV) for pharmacological agents as we...

BioArtProducts GmbH

BioArtProducts agiert auf dem Gebiet des Qualitätsmanagements und bietet eine praxisorientierte Beratung beim Aufbau von Qualitätsmanagementsystemen.Zudem ist das Unternehmen im Bereich der Forschun...

tecrisk GmbH

The company tecrisk GmbH was founded in 1998 and is specialized in:Scientific technical risk analysisTechnology assessmentRisk analysis for biotechnology and high containment facilitiesConsultation of...

A. Duschek GmbH.

Unsere Firma wurde 1944 von Herrn Alois Duschek als Einzelhandelsfirma für medizinische Produkte gegründet. Heute bieten wir unseren Kunden ein umfangreiches Produktangebot im medizinisch-chirurgisc...

More Information about "Polymun Scientific Immunbiologische Forschung GmbH" on BioPortfolio

We have published hundreds of Polymun Scientific Immunbiologische Forschung GmbH news stories on BioPortfolio along with dozens of Polymun Scientific Immunbiologische Forschung GmbH Clinical Trials and PubMed Articles about Polymun Scientific Immunbiologische Forschung GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Polymun Scientific Immunbiologische Forschung GmbH Companies in our database. You can also find out about relevant Polymun Scientific Immunbiologische Forschung GmbH Drugs and Medications on this site too.

Quick Search


Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Corporate Database Quicklinks

Searches Linking to this Company Record